ASH Leukemia | Conference

Naval Daver, MD, Provides Perspective on Updates in Acute Myeloid Leukemia
January 12, 2020

Naval Daver, MD, explains the progress made on 3 abstracts he’s involved with regarding acute myeloid leukemia (AML) at the ASH Annual Meeting and Exposition.

Courtney DiNardo, MD, MSCE, on Enasidenib Plus Azacitidine in Newly Diagnosed AML
January 10, 2020

Courtney DiNardo, MD, MSCE, elaborated on interim phase II results regarding enasibenib plus azacitidine in patients with newly diagnosed acute myeloid leukemia, and the results from the QUAZAR trial.

Ibrutinib/Rituximab Combo Induced Superior PFS in Older Patients with CLL
December 09, 2019

The combination of ibrutinib and rituximab demonstrated superior progression-free survival in older patients with previously untreated chronic lymphocytic leukemia.